FDA Issues Final Guidance on Compounding With Bulk Drug Substances
January 07, 2025
January 07, 2025
WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) has announced the availability of final guidance for industry titled "Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act." This new policy finalizes the draft issued in December 2023 and replaces the guidance published in January 2017.
It specifically pertains to human drug product compounding by licensed pharmacists or physicians, allo . . .
It specifically pertains to human drug product compounding by licensed pharmacists or physicians, allo . . .